AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

AI-Assisted Personalized Heat-Risk Alerts

RecruitingNAAges 18 Years - anyAllNational University of Medical Sciences, Pakistan
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This two-arm randomized controlled trial will evaluate whether an artificial intelligence-assisted personalized heat-risk alert system reduces heat-related illness symptom burden among adults with chronic conditions. The intervention will integrate prespecified clinical characteristics with the Pakistan Meteorological Department's same-day forecast maximum temperature to classify individual heat-related acute clinical-event risk and deliver personalized alerts through a mobile application. The control group will receive a generic PMD heat-health advisory through the same application.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older attending the outpatient department of the selected tertiary-care hospital during the recruitment period. * Have a documented diagnosis of at least one chronic non-communicable disease associated with increased susceptibility to heat-related illness, including hypertension, type 2 diabetes mellitus, chronic kidney disease, cardiovascular disease, or obesity (BMI โ‰ฅ30 kg/mยฒ). * Have access to a personal smartphone capable of receiving study heat-risk alert notifications. * Be able to read Urdu or English, or have a household member/caregiver available to read and explain study alerts when required. * Be willing and able to provide written informed consent. * Intend to remain within the study catchment area for the duration of the six-week study period to facilitate follow-up. Exclusion Criteria: * Patients requiring immediate emergency treatment or hospital admission at the time of recruitment. * Individuals with severe cognitive impairment, dementia, psychotic illness, or another medical condition that limits their ability to understand study procedures or provide informed consent. * Patients with terminal illness or those receiving palliative care. * Individuals with severe visual, hearing, or communication impairments that prevent effective receipt of the study alert intervention and outcome assessment without a reliable caregiver. * Pregnant women, because pregnancy has distinct physiological responses to heat exposure and would require separate clinical risk stratification beyond the scope of this study. * Participants currently enrolled in another clinical trial or structured behavioral intervention related to heat-health, climate adaptation, or chronic disease self-management. * Participants who are unable or unwilling to comply with study procedures or complete the required follow-up assessment.
๐Ÿ’Š

What it tests

  • AI-Assisted Personalized Heat-Risk Alert System
  • Generic PMD Heat-Health Advisory
๐Ÿ“

Where

1 site
DHQ Teaching Hospital Gujranwala
Gujranwala, Pakistan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy